Exicure (XCUR) Competitors $5.60 -0.01 (-0.09%) Closing price 08/29/2025 03:58 PM EasternExtended Trading$5.97 +0.36 (+6.51%) As of 08/29/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XCUR vs. THTX, HURA, ALTS, CRDF, GNLX, CLLS, MIST, CABA, FBRX, and BHSTShould you be buying Exicure stock or one of its competitors? The main competitors of Exicure include Theratechnologies (THTX), TuHURA Biosciences (HURA), ALT5 Sigma (ALTS), Cardiff Oncology (CRDF), Genelux (GNLX), Cellectis (CLLS), Milestone Pharmaceuticals (MIST), Cabaletta Bio (CABA), Forte Biosciences (FBRX), and BioHarvest Sciences (BHST). These companies are all part of the "pharmaceutical products" industry. Exicure vs. Its Competitors Theratechnologies TuHURA Biosciences ALT5 Sigma Cardiff Oncology Genelux Cellectis Milestone Pharmaceuticals Cabaletta Bio Forte Biosciences BioHarvest Sciences Exicure (NASDAQ:XCUR) and Theratechnologies (NASDAQ:THTX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings. Do analysts rate XCUR or THTX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exicure 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Theratechnologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, XCUR or THTX? Theratechnologies has higher revenue and earnings than Exicure. Theratechnologies is trading at a lower price-to-earnings ratio than Exicure, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExicure$500K70.85-$9.70M-$3.88-1.44Theratechnologies$85.87M1.73-$8.31M-$0.19-17.05 Does the media favor XCUR or THTX? In the previous week, Exicure and Exicure both had 1 articles in the media. Exicure's average media sentiment score of 1.88 beat Theratechnologies' score of 1.71 indicating that Exicure is being referred to more favorably in the media. Company Overall Sentiment Exicure Very Positive Theratechnologies Very Positive Do institutionals and insiders believe in XCUR or THTX? 42.8% of Exicure shares are held by institutional investors. 8.4% of Exicure shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is XCUR or THTX more profitable? Exicure has a net margin of 0.00% compared to Theratechnologies' net margin of -10.85%. Theratechnologies' return on equity of 0.00% beat Exicure's return on equity.Company Net Margins Return on Equity Return on Assets ExicureN/A -192.16% -84.30% Theratechnologies -10.85%N/A -9.83% Which has more volatility and risk, XCUR or THTX? Exicure has a beta of 3.85, indicating that its share price is 285% more volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. SummaryExicure and Theratechnologies tied by winning 7 of the 14 factors compared between the two stocks. Get Exicure News Delivered to You Automatically Sign up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XCUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XCUR vs. The Competition Export to ExcelMetricExicureMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.44M$3.08B$5.71B$9.76BDividend YieldN/A2.28%6.66%4.48%P/E Ratio-1.4420.7883.1026.57Price / Sales70.85393.33544.91112.35Price / CashN/A43.5325.6628.92Price / Book5.009.7811.766.08Net Income-$9.70M-$54.01M$3.27B$265.84M7 Day Performance-4.84%-0.71%0.07%-0.10%1 Month Performance-20.50%8.53%8.40%5.86%1 Year Performance184.52%7.03%62.30%18.11% Exicure Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XCURExicure1.9337 of 5 stars$5.61-0.1%N/A+184.5%$35.44M$500K-1.4450Positive NewsTHTXTheratechnologiesN/A$3.26+0.2%N/A+153.1%$149.67M$85.87M-17.13140News CoverageHURATuHURA Biosciences1.4873 of 5 stars$2.99+1.4%$12.67+323.6%N/A$149.65MN/A0.00N/AAnalyst DowngradeALTSALT5 Sigma0.7412 of 5 stars$6.89+1.3%N/A+227.0%$148.68M$12.53M0.00170Gap DownHigh Trading VolumeCRDFCardiff Oncology2.0485 of 5 stars$2.21-0.2%$10.10+358.0%-9.1%$146.69M$545K-2.5320GNLXGenelux1.6773 of 5 stars$3.83+2.4%$17.75+363.3%+53.5%$145.04M$10K-4.4710Positive NewsCLLSCellectis2.9758 of 5 stars$2.60-3.5%$4.00+54.1%+7.1%$144.51M$49.22M-3.17290News CoverageMISTMilestone Pharmaceuticals1.6347 of 5 stars$1.67-1.5%$5.00+200.3%+29.6%$141.52MN/A-1.9830Positive NewsCABACabaletta Bio2.4566 of 5 stars$1.55-2.8%$14.43+833.9%-74.2%$141.31MN/A-0.5750Positive NewsFBRXForte Biosciences2.8509 of 5 stars$11.27-0.5%$68.00+503.6%+39.2%$140.06MN/A-0.695Gap UpBHSTBioHarvest SciencesN/A$8.26-0.5%$13.67+65.5%N/A$135.63M$25.19M-11.80N/AGap Down Related Companies and Tools Related Companies Theratechnologies Alternatives TuHURA Biosciences Alternatives ALT5 Sigma Alternatives Cardiff Oncology Alternatives Genelux Alternatives Cellectis Alternatives Milestone Pharmaceuticals Alternatives Cabaletta Bio Alternatives Forte Biosciences Alternatives BioHarvest Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XCUR) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exicure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XCUR Stock Alerts